Mean predicted HAQ score for patients in remission, LDA, MDA and HDA
| Remission | LDA | MDA | HDA | |
|---|---|---|---|---|
| Mean (95% CI) | Mean (95% CI) | Mean (95% CI) | Mean (95% CI) | |
| DAS | 0.48 (0.40 to 0.55) | 0.61 (0.53 to 0.69) | 0.83 (0.75 to 0.91) | 1.24 (1.14 to 1.33) |
| DAS CRP | 0.49 (0.41 to 0.57) | 0.63 (0.55 to 0.71) | 0.87 (0.79 to 0.95) | 1.27 (1.17 to 1.38) |
| DAS28 | 0.49 (0.41 to 0.57) | 0.60 (0.52 to 0.68) | 0.76 (0.67 to 0.84) | 1.20 (1.10 to 1.29) |
| DAS28 CRP | 0.52 (0.44 to 0.60) | 0.62 (0.54 to 0.70) | 0.80 (0.72 to 0.89) | 1.28 (1.18 to 1.38) |
| SDAI | 0.47 (0.39 to 0.55) | 0.60 (0.52 to 0.68) | 0.83 (0.75 to 0.92) | 1.24 (1.14 to 1.33) |
| CDAI | 0.46 (0.38 to 0.54) | 0.60 (0.52 to 0.68) | 0.83 (0.74 to 0.91) | 1.18 (1.09 to 1.28) |
| DAS 0–1 | 0.48 (0.40 to 0.56) | 0.61 (0.53 to 0.70) | 0.84 (0.76 to 0.92) | 1.26 (1.16 to 1.36) |
| DAS TJC53 | 0.47 (0.39 to 0.55) | 0.60 (0.52 to 0.68) | 0.77 (0.69 to 0.85) | 1.13 (1.03 to 1.22) |
| DAS TJC44 | 0.48 (0.40 to 0.56) | 0.60 (0.52 to 0.68) | 0.78 (0.70 to 0.86) | 1.14 (1.05 to 1.24) |
Covariates and factors appearing in the model are fixed at the following values: baseline HAQ 1.4; visit 10.6; age 53.9; treatment group 1; female gender.
CDAI, Clinical Disease Activity Index; CRP, C reactive protein; DAS, Disease Activity Score; DAS 0–1, Disease Activity Score with RAI 0–1; DAS28, Disease Activity Score in 28 joints; HAQ, Health Assessment Questionnaire; HDA, high disease activity; LDA, low disease activity; MDA, moderate disease activity; SDAI, Simplified Disease Activity Index; TJC44, tender joint count 44 joints; TJC53, tender joint count 53 joints.